Novartis Investigative Site

Valladolid 47012

0 studies enrolling now · 5 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Carcinoma, Renal Cell, Pulmonary Arterial Hypertension, Relapsing Multiple Sclerosis, Systemic Lupus Erythematosus

Studies at this site

• Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1) — Running, not enrolling
• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma — Completed
• Imatinib (QTI571) in Pulmonary Arterial Hypertension — Completed